Cloudpharm announces the approval of the funded project “OSTEOME” in collaboration with the Musculoskeletal Diseases Research Laboratory “Th. Garofalidis ”of the Medical School of EKPA, the Institute of Chemical Biology of the National Research Foundation (NHRF), the Panhellenic Skeletal Health Association“ PETALOUDA ” and Life N.L.B. Within its main objectives, is the design and development of a dietary supplement for osteoporosis through the gut microbiome mechanisms. Study of the effectiveness and tolerability of the innovative dietary supplement.
The project has a duration of 3 years and is funded within the action RESEARCH – CREATE – INNOVATE B cycle.